Wun‐Rong Lin
Papers
2
Total Citations
6
H-Index
2
About
Dr. Wun‐Rong Lin is a leading urological oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a disease with unusually high prevalence in Taiwan. His work has been instrumental in shaping treatment strategies for this challenging cancer, which accounts for 30-40% of urothelial cancers in the region. Dr. Lin’s major contributions include comprehensive nationwide collaborative studies evaluating surgical outcomes. His landmark 2024 study on segmental ureterectomy (SU) provided critical evidence supporting this organ-sparing approach for selected mid- and distal ureteral tumors, directly informing clinical guidelines in high-endemic areas. In his 2025 comparative analysis, Dr. Lin examined survival outcomes between minimally invasive and open radical nephroureterectomy (RNU), addressing the growing adoption of laparoscopic techniques. These studies, with citations accumulating rapidly, have established foundational data for UTUC management in endemic populations. Dr. Lin’s work bridges a critical gap in the literature, as most UTUC research originates from non-endemic regions. His contributions are particularly valuable for surgeons and oncologists treating patients in areas with high disease burden, offering evidence-based guidance for both nephron-sparing and radical surgical approaches in this unique epidemiological context.
Research Focus
Key Achievements
Top Papers
- 1
- 2